MedTrace Logo

OCS Liver Perfusion (OLP) Post-Approval Registry

NCT05074160 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2025-04-10

No results posted yet for this study

Summary

The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.

Conditions

  • Liver Transplant

Interventions

DEVICE

OCS Liver

Multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.

Sponsors & Collaborators

  • TransMedics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-14
Primary Completion
2024-03-22
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05074160 on ClinicalTrials.gov